Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H16O3 |
| Molecular Weight | 244.2857 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H](C)C1=CC=C2C=C(OC)C=CC2=C1
InChI
InChIKey=ZFYFBPCRUQZGJE-JTQLQIEISA-N
InChI=1S/C15H16O3/c1-10(15(16)18-3)11-4-5-13-9-14(17-2)7-6-12(13)8-11/h4-10H,1-3H3/t10-/m0/s1
Naproxen methyl ester, a mixture of two isomers R and S, is the precursor of therapeutically important nonsteroidal anti-inflammatory drug naproxen. Naproxen methyl ester can be enantioselectively hydrolyzed by lipases or (S)-enantioselective esterase could catalyze the selective hydrolysis of the (S)-Naproxen methyl ester, giving optically pure (S)-naproxen. In addition, S-naproxen methyl ester is used as a tool for identification and determination of new stereo selective carboxylesterase activities.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
571OJX4PDN
Created by
admin on Sat Dec 16 08:34:57 GMT 2023 , Edited by admin on Sat Dec 16 08:34:57 GMT 2023
|
PRIMARY | |||
|
9899603
Created by
admin on Sat Dec 16 08:34:57 GMT 2023 , Edited by admin on Sat Dec 16 08:34:57 GMT 2023
|
PRIMARY | |||
|
DTXSID50180780
Created by
admin on Sat Dec 16 08:34:57 GMT 2023 , Edited by admin on Sat Dec 16 08:34:57 GMT 2023
|
PRIMARY | |||
|
26159-35-3
Created by
admin on Sat Dec 16 08:34:57 GMT 2023 , Edited by admin on Sat Dec 16 08:34:57 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
